Literature DB >> 11590625

Relative frequency of malaria pigment-carrying monocytes of nonimmune and semi-immune patients from flow cytometric depolarized side scatter.

B Krämer1, M P Grobusch, N Suttorp, J Neukammer, H Rinneberg.   

Abstract

BACKGROUND: Recently, it was observed that malaria can be detected by performing automated complete blood count analysis including depolarization measurement of scattered laser light. To explain large discrepancies in sensitivity and specificity observed in semi-immune and nonimmune malaria patients, we determined the relative frequencies of malaria pigment-carrying monocytes (PCM) by flow cytometric measurements combined with rare event analysis.
METHODS: An experimental cell-sorting unit utilizing argon, krypton, and helium-neon lasers measured the relative frequencies of leukocytes of malaria patients. Single white blood cells showing high intensity in their depolarized side scatter were sorted for subsequent microscopic analysis.
RESULTS: From microscopic inspection of sorted cells, we identified malaria PCM as a distinct cluster in scatter diagrams that is well separated from normal leukocytes. For nonimmune patients, the average relative frequency of PCM is 1.5 x 10(-4) (median), for semi-immune patients 8.8 x 10(-4), and for malaria-negative persons 4.4 x 10(-6). Results derived from depolarized side scatter at 488, 633, or 647 nm agree well. Furthermore, malaria pigment-carrying neutrophilic granulocytes were identified microscopically after sorting. We discuss briefly how pigment-carrying neutrophils might be differentiated from normal leukocytes and PCM by using flow cytometry and measuring depolarized side scatter at two wavelengths.
CONCLUSION: Our results confirm the feasibility of malaria detection by flow cytometry for semi-immune patients and extend malaria detection to nonimmune patients with low frequencies of PCM. High sensitivity and specificity for malaria detection were obtained. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590625     DOI: 10.1002/1097-0320(20011001)45:2<133::aid-cyto1155>3.0.co;2-k

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  7 in total

1.  Comparative analysis of gene expression changes mediated by individual constituents of hemozoin.

Authors:  Alexandra C Schrimpe; David W Wright
Journal:  Chem Res Toxicol       Date:  2009-03-16       Impact factor: 3.739

2.  Co-infection of malaria and gamma-herpesvirus: exacerbated lung inflammation or cross-protection depends on the stage of viral infection.

Authors:  A Haque; N Rachinel; M R Quddus; S Haque; L H Kasper; E Usherwood
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

Review 3.  Automated haematology analysis to diagnose malaria.

Authors:  Germán Campuzano-Zuluaga; Thomas Hänscheid; Martin P Grobusch
Journal:  Malar J       Date:  2010-11-30       Impact factor: 2.979

4.  Simple flow cytometric detection of haemozoin containing leukocytes and erythrocytes for research on diagnosis, immunology and drug sensitivity testing.

Authors:  Rosangela Frita; Maria Rebelo; Ana Pamplona; Ana M Vigario; Maria M Mota; Martin P Grobusch; Thomas Hänscheid
Journal:  Malar J       Date:  2011-03-31       Impact factor: 2.979

5.  A simplified, low-cost method for polarized light microscopy.

Authors:  Richard J Maude; Wanchana Buapetch; Kamolrat Silamut
Journal:  Am J Trop Med Hyg       Date:  2009-11       Impact factor: 2.345

6.  A novel flow cytometric hemozoin detection assay for real-time sensitivity testing of Plasmodium falciparum.

Authors:  Maria Rebelo; Claudia Sousa; Howard M Shapiro; Maria M Mota; Martin P Grobusch; Thomas Hänscheid
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

7.  Full blood count and haemozoin-containing leukocytes in children with malaria: diagnostic value and association with disease severity.

Authors:  Thomas Hänscheid; Matthias Längin; Bertrand Lell; Marc Pötschke; Sunny Oyakhirome; Peter G Kremsner; Martin P Grobusch
Journal:  Malar J       Date:  2008-06-12       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.